PRELUDE CAPITAL MANAGEMENT, LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 75 filers reported holding ALBIREO PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q3 2020$3,000
-66.7%
100
-70.6%
0.00%
Q4 2019$9,000
+12.5%
340
-10.1%
0.00%
Q3 2019$8,000
-69.2%
378
-53.9%
0.00%
-100.0%
Q2 2019$26,000
+8.3%
820
+8.5%
0.00%0.0%
Q1 2019$24,000
+14.3%
756
-11.9%
0.00%0.0%
Q4 2018$21,000
-73.4%
858
-64.1%
0.00%
-80.0%
Q3 2018$79,000
+9.7%
2,388
+17.6%
0.01%0.0%
Q2 2018$72,000
-13.3%
2,030
-20.8%
0.01%
-16.7%
Q1 2018$83,000
+62.7%
2,563
+28.2%
0.01%
+50.0%
Q4 2017$51,0002,0000.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders